RCYC
NVO

Richard C. Young & Co’s Novo Nordisk NVO Stock Holding History

Richard C. Young & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-347,774
Closed -$11.4M – 81
2020
Q2 		$11.4M Sell
347,774
-15,546
-4% -$496K 1.9% 18
2020
Q1 		$10.9M Buy
363,320
+5,070
+1% +$151K 2.12% 14
2019
Q4 		$10.4M Buy
358,250
+7,784
+2% +$216K 1.73% 24
2019
Q3 		$9.06M Buy
350,466
+6,778
+2% +$171K 1.63% 26
2019
Q2 		$8.77M Buy
343,688
+8,018
+2% +$198K 1.66% 25
2019
Q1 		$8.78M Buy
+335,670
New +$8.25M 1.68% 21

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Richard C. Young & Co's NVO Position: Q3 2020 in Review

Richard C. Young & Co sold out of Novo Nordisk (NVO) in Q3 2020, closing a stake of 347,774 shares — an estimated $11.4M sold.

Richard C. Young & Co first reported a position in NVO in Q1 2019 and held it in 6 quarters. The position peaked at $11.4M in Q2 2020. 660 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

  • Richard C. Young & Co reported no remaining Novo Nordisk position as of Q3 2020 after selling out during the quarter.
  • Richard C. Young & Co sold 347,774 Novo Nordisk shares in Q3 2020, an estimated $11.4M.
  • Richard C. Young & Co first reported a position in Novo Nordisk in Q1 2019 and held it in 6 quarters.
  • Richard C. Young & Co's Novo Nordisk position peaked at $11.4M in Q2 2020.
  • 660 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on Richard C. Young & Co's 13F filing for Q3 2020, filed 12 Nov 2020.